Clinical implications of insulin-like growth factors through the presence of their binding proteins and receptors expressed in gynecological cancers

European Journal of Gynaecological Oncology

Volumn 25, Issue 2, 2004, Pages 187-191

  Hirano, S ^a   Ito, N ^a   Takahashi, S ^a   Tamaya, T ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; Clinical implication; Endometrial cancer; IGF R; IGFBP; Ovarian cancer

Indexed keywords

BINDING PROTEIN; MEMBRANE RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CANCER RISK; CANCER STAGING; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG RECEPTOR BINDING; ENDOMETRIUM CANCER; EPITHELIUM CELL; FEMALE; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MESSENGER RNA SYNTHESIS; MITOGENICITY; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN RNA BINDING; TUMOR GROWTH; UTERINE CERVIX CANCER;

ADENOCARCINOMA; CARCINOMA, ENDOMETRIOID; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA PRIMERS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 1442327490     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Clemmons D., Busby W., Arai T., Nam T., Clarke J., Jones J. et al.: "Role of insulin-like growth factor binding proteins in the control of IGF actions". Prog. Growth Factor. Res., 1995, 6, 357.
2. Daughaday W., Rotwein P.: "Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations". Endocr. Rev., 1989, 10, 68.
3. Rosenfeld R., Lamson G., Pham H., Oh Y., Conover C., DeLeon D. et al.: "Insulinlike growth factor-binding proteins". Recent. Prog. Horm. Res., 1990, 46, 99.
4. Jones J., Clemmons D.: "Insulin-like growth factors and their binding proteins: biological actions". Endocr. Rev., 1995, 16, 3.
5. Rutanen E., Pekonen F., Nyman T., Wahlstrom T.: "Insulin-like growth factors and their binding proteins in benign and malignant uterine diseases". Growth Regul., 1993, 3, 74.
6. Maccario M., Tassone F., Grottoli S., Rossetto R., Gauna C., Ghigo E.: "Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity". Ann. Endocrinol. (Paris), 2002, 63, 140.
7. Wang Y., Sun Y.: "Insulin-like growth factor receptor-1 as an anticancer target: blocking transformation and inducing apoptosis". Curr. Cancer Drug. Targets, 2002, 2, 191.
8. Katsaros D., Yu H., Levesqu eM., Danese S., Gent aF., Richiardi G. et al.: "IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival". Eur. J. Cancer, 2001, 37, 478.
9. Bermont L., Fauconnet S., Lamielle F., Adessi G.: "Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation". Cell. Mol. Biol., 2000, 46, 1173.
10. Rutanen E., Nyman T., Lehtovirta P., Ammala M., Pekonen F.: "Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors". Int. J. Cancer 1994, 59, 307.
11. Moschos S.J., Mantzoros C.S.: "The role of the IGF system in cancer: from basic to clinical studies and clinical applications". Oncology, 2002, 63, 317.
12. Bermont L., Lamielle F., Fauconnet S., Esumi H., Weisz A., Adessi G.: "Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells". Int. J. Cancer, 2000, 85, 117.
13. Furstenberger G., Senn H.: "Insulin-like growth factors and cancer". Lancet Oncol., 2002, 3, 298.
14. Nagamani M., Stuart C., Dunhardt P., Doherty M.: "Specific binding sites for insulin and insulin-like growth factor I in human endometrial cancer". Am. J. Obstet. Gynecol., 1991, 165, 1865.
15. Ayabe T., Tsutsumi O., Sakai H., Yoshikawa H., Yano T., Kurimoto F. et al.: "Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer". Endocr. J., 1997, 44, 419.
16. Park J., McCusker R., Vanderhoof J., Mohammadpour H., Harty R., MacDonald R.: "Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation". Endocrinology, 1992, 131, 1359.
17. Barreca A., DeLuca M., Del Monte P., Bondanza S., Damonte G., Cariola G. et al.: "In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors". J. Cell. Physiol., 1992, 151, 262.
18. Richards J., Russell D., Ochsner S., Hsieh M., Doyle K., Falender A. et al.: "Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization". Recent Prog. Horm. Res., 2002, 57, 195.
19. Gambineri A., Pelusi C., Vicennati V., Pagotto U., Pasquali R.: "Obesity and the polycystic ovary syndrome". Int. J. Obes. Relat. Metab. Disord., 2002, 26, 883.
20. Burns K., Matzuk M.: "Genetic models for the study of gonadotropin actions". Endocrinology, 2002, 143, 2823.
21. Druckmann R., Rohr U.: "IGF-1 in gynaecology and obstetrics: update 2002". Maturitas, 2002, 41 (suppl. 1), S65.
22. Wood J., Strauss Jr.: "Multiple signal transduction pathways regulate ovarian steroidogenesis". Rev. Endocr. Metab. Disord., 2002, 3, 33.
23. Jesionowska H., R. H., H.J. G., Bi P.: "Determination of insulin and insulin-like growth factors in the ovarian circulation". Fertil. Steril., 1990, 53, 88.
24. Hofmann J., Wegmann B., Hackenberg R., Kunzmann R., Schulz K., Havemann K.: "Production of insulin-like growth factor binding proteins by human ovarian carcinoma cells". J. Cancer Res. Clin. Oncol., 1994, 120, 137.
25. Krywicki R., Figueroa J., Jackson J., Kozelsky T., Shimasaki S., Von Hoff D. et al.: "Regulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogen". Eur. J. Cancer, 1993, 29A, 2015.
26. Schedlich L., Graham L.: "Role of insulin-like growth factor binding protein-3 in breast cancer cell growth". Microsc. Res. Tech., 2002, 59, 12.
27. Schernhammer E.: "In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor ?" Cancer Causes Control., 2002, 13, 505.
28. Hembree J., Agarwal C., Eckert R.: "Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor I". Cancer Res., 1994, 54, 3160.
29. Laemmli W.: "Cleavage of structural proteins during the assembly of the head of bacteriophage lambda". Nature, 1970, 227, 680.
30. Lowry O.H., Rosenbrough N., Farr A.L., Randall R.J.: "Protein measurement with the Folin phenol reagent". J. Biol. Chem., 1951, 193, 265.
31. Chomczynski P., Sacchi N.: "Single-step method of RNA isolation by acid guanidium thiocyanate-chloroform extraction". Anal. Biochem., 1987, 162, 156.
32. Buyalos R., Pekonen F., Halme J., Judd H., Rutanen E.: "The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome". Am. J. Obstet. Gynecol., 1995, 172, 932.
33. Toneguzzo F., Glynn S., Levi E., Mjolseness S., Hayday A.: "Use of a chemically modified T7 DNA polymerase for manual and automated sequencing of supercoiled DNA". Biotechniques, 1988, 6, 460.
34. Lala P., Lee B., Xu G., Chakraborty C.: "Human placental trophoblast as an in vitro model for tumor progression". Can. J. Physiol. Pharmacol., 2002, 80, 142.
35. Chakraborty C., Gleeson L., McKinnon T., Lala P.: "Regulation of human trophoblast migration and invasiveness". Can. J. Physiol. Pharmacol., 2002, 80, 116.
36. Giudie L.: "Insulin-like growth factors and ovarian follicular development". Endocr. Rev., 1992, 13, 641.
37. Yee D., Morales F., Hamilton T., VonHoff D.: "Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer". Cancer Res., 1991, 51, 5107.
38. Kanety H., Kattan M., Goldberg I., Kopolovic J., Ravia J., Menczer J. et al.: "Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid". Br. J. Cancer, 1996, 73, 1069.
39. Karasik A., Menczer J., Pariente C., Kanety H.: "Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer". J. Clin. Endocrinol. Metab., 1994, 78, 271.
40. Bast R.C. Jr., Xu F.J., Yu Y.H., Barnhill S., Zhang Z., Mills G.B.: "CA 125: the past and the future". Int. J. Biol. Markers, 1998, 13, 179.